Skip to main content

ExodusPoint Capital Management, LP

Position in BSX — Boston Scientific Corp

CIK 1736225 NEW YORK, NY

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,551,180
+$2,013,152 QoQ
Shares Held
504,948
+62.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#223
of 1,468 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$1,568,750
CallShares
25,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $464,643,980 across 33 Medical Devices names. BSX ranks #2 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BSX
Boston Scientific Corp
This page
504,948 $21,551,180

All Filings in BSX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,551,180 504,948
2026-03-31 $1,568,750 25,000
2026-03-31 $19,538,028 311,363
2025-12-31 $16,438,340 172,400
2025-09-30 $19,784,719 202,650
2025-06-30 $81,187,674 755,867
2025-03-31 $56,620,413 561,265
2024-12-31 $27,096,472 303,364
2024-09-30 $84,095,311 1,003,524
2024-06-30 $52,343,157 679,693
2024-03-31 $15,602,638 227,809
2023-06-30 $19,606,759 362,484
2023-03-31 $8,043,573 160,775
2022-06-30 $3,439,834 92,295
2022-03-31 $7,994,655 180,507
2021-12-31 $3,881,525 91,373
2021-09-30 $5,125,487 118,126
2021-06-30 $2,628,756 61,477
2021-03-31 $5,159,659 133,497
2020-12-31 $8,788,804 244,473
2020-12-31 $4,137,845 115,100
2020-09-30 $638,832 16,719
2020-06-30 $4,859,575 138,410
2020-03-31 $3,886,428 119,106